Adamas Pharma

ADMS NASDAQ
5.97
-0.06
-1.00%
Opening 10:45 07/19 EDT
Open
6.02
Prev Close
6.03
High
6.05
Low
5.97
Volume
56.95K
Avg Vol (3M)
363.82K
52 Week High
29.49
52 Week Low
4.200
% Turnover
0.21%
Market Cap
164.37M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Adamas Pharma ADMS stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Adamas Pharmaceuticals, Inc. is a pharmaceutical company. The Company is engaged in developing medicines to manage the daily lives of those affected by chronic neurologic disorders. It offers a platform based on an understanding of time dependent biologic effects of disease activity and drug response to achieve relief without tolerability issues. It has developed a portfolio of chrono-synchronous therapies to address chronic neurologic disorders. Its first product candidate is ADS-5102, a chrono-synchronous amantadine therapy, for the treatment of levodopa-induced dyskinesia (LID) in patients with Parkinson's disease (PD). It has completed Phase II proof-of-concept study of ADS-5102 in these patients. Its Phase III clinical program included three placebo-controlled trials: EASED, EASE LID and EASE LID 3. Its second product candidate is ADS-4101, an extended-release version of single-agent compound for the treatment of epilepsy (partial onset seizures).
MORE >

Recently

Name
Price
%Change